Corrigendum to "Development and validation of the current opioid misuse measure" [Pain 130 (2007) 144-56] (DOI:10.1016/j.pain.2007.01.014);Development and validation of the Current Opioid Misuse Measure

Pain

Volumn 130, Issue 1-2, 2007, Pages 144-156

  Butler, Stephen F ^a   Budman, Simon H ^a   Fernandez, Kathrine C ^a   Houle, Brian ^a   Benoit, Christine ^a   Katz, Nathaniel ^a,c,d   Jamison, Robert N ^b  

^a INFLEXXION INC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Analgesic Research   (United States)

Author keywords

Aberrant drug behaviors; Addiction; Chronic pain; Opioids; Substance abuse

Indexed keywords

ALCOHOL; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABINOID; COCAINE; CODEINE; DEXTROPROPOXYPHENE; DIAMORPHINE; DIHYDROCODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE; OXYMORPHONE; PETHIDINE; PHENCYCLIDINE; TRAMADOL;

ADULT; AGED; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG MISUSE; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OPIATE ADDICTION; PRESCRIPTION; PRIORITY JOURNAL;

EID: 34247523880     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.12.020     Document Type: Erratum

References (38)

1. Adams L.L., Gatchel R.J., Robinson R.C., Polatin P., Gajraj N., Deschner M., and Noe C. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symp Manage 27 (2004) 440-459
2. Akbik H., Butler S.F., Budman S.H., Fernandez K., Katz N.P., and Jamison R.N. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage 32 (2006) 287-293
3. American Pain Society. Principles of analgesic use in the treatment of acute pain and cancer pain (4th ed). Glenview, IL: American Pain Society, 1999.
4. American Pain Society. Guideline for the management of pain in osteoarthritis, rheumatoid arthritis, and juvenile chronic arthritis. Clinical practice guideline number 2. Glenview, IL: American Pain Society, 2002.
5. Butler S.F. The baby or the bath water?. Addiction 99 (2004) 413-414
6. Butler S.F., Budman S.H., Fernandez K., and Jamison R.N. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 112 (2004) 65-75
7. Chabal C., Erjavec M.K., Jacobson L., Mariano A., and Chaney E. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain 13 (1997) 150-155
8. Coambs R.E., Jarry J.L., Santhiapillai A.C., Abrahamsohn R.V., and Atance C.M. The SISAP: A new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain in general medical practice. Pain Res Manage 1 (1996) 155-162
9. Compton P.J., Darakjian J., and Miotto K. Screening for addiction in patients with chronic pain and 'problematic' substance use: evaluation of a pilot assessment tool. J Pain Symp Manage 16 (1998) 355-363
10. Crowne D.P., and Marlowe D. The Approval Motive: Studies in Evaluative Dependence (1964), Wiley, New York, NY
11. Friedman R., Li V., and Mehrotra D. Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med 4 (2003) 181-184
12. General Accounting Office. Prescription Drugs: OxyContin Abuse and Diversion and Efforts to Address the Problem. Available at: http://www.gao.gov/new.items/d04110.pdf. December, 2003.
13. Gilson A.M., Ryan K.M., Joranson D.E., and Dahl J.L. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Sym Manage 28 (2004) 176-188
14. Hampton T. Physicians advised on how to offer pain relief while preventing opioid abuse. JAMA 292 (2004) 1164-1166
15. Jackson K.M., and Trochim W.M.K. Concept mapping as an alternative approach for the analysis of open-ended survey responses. Organiz Res Method 5 (2002) 307-336
16. Joranson D.E., Ryan K.M., Aaron M., and Dahl J.L. Trends in medical use and abuse of opioid analgesics. JAMA 283 (2000) 1710-1714
17. Kirsh K.L., Whitcomb L.A., Donaghy D., and Passik S.D. Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain 18 Suppl (2002) S52-S60
18. Michna E., Ross E.L., Hynes W.L., Nedeljkovic S.S., Soumekh S., Janfaza D., Palombi D., and Jamison R.N. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Sym Manage 28 (2004) 250-258
19. Michna E., Jamison R.N., Pham L.D., Ross E.L., Janfaza D., Nedeljkovic S.S., Narang S., Palombi D., and Wasan A.D. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain 23 (2007) 173-179
20. National Institutes of Health (NIH). Prescription opioid use and abuse in the treatment of pain. RFA-DA-06-005. Available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-06-005.html. Accessed on 1/18/2007.
21. Nedeljkovic S.S., Wasan A.D., and Jamison R.N. Assessment of efficacy of long-term opioid therapy in pain patients with substance abuse potential. Clin J Pain 18 Suppl (2002) S39-S51
22. Nunnally J.C., and Bernstein I.H. Psychometric Theory. 3rd ed. (1994), McGraw-Hill, New York
23. Obuchowski N., and McClish D. Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Statistics Med 16 (1997) 1529-1542
24. Passik S.D., and Kirsh K.L. The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain. Pain Med 4 (2003) 186-189
25. Passik S.D., Kirsh K.L., Whitcomb L., Portenoy R.K., Katz N.P., Kleinman L., Dodd S.L., and Schein J.R. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther 26 (2004) 552-561
26. Reynolds W.M. Development of reliable and valid short forms of the Marlowe-Crowne Social Desirability Scale. J Clin Psychol 38 (1982) 119-125
27. Robinson R.C., Gatchel R.J., Polatin P., Deschner M., Noe C., and Gajraj N. Screening for problematic prescription opioid use. Clin J Pain 17 (2001) 220-228
28. Sackett D.L., Haynes R.B., Guyatt G.H., and Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd ed. (1991), Little, Brown & Co, Boston, MA
29. Savage S.R. Assessment for addiction in pain-treatment settings. Clin J Pain 18 (2002) S28-S38
30. Stewart A.L., Hayes R.D., and Ware J.E. Methods of constructing health measures. In: Stewart A.L., and Ware J.E. (Eds). Measuring Functioning and Well-being (1993), Duke University Press, Durham, NC
31. Streiner D.L. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Person Assess 80 (2003) 99-103
32. Streiner D.L. Being inconsistent about consistency: when coefficient alpha does and doesn't matter. J Person Assess 80 (2003) 217-222
33. Trochim W.M.K. An introduction to concept mapping. Eval Prog Planning 12 (1989) 1-16
34. Trochim WMK. The reliability of concept mapping. Paper presented at the Annual Meeting of the American Evaluation Association, Dallas, 1993.
35. Trochim W.M.K., Cook J.A., and Setz R.J. Concept mapping to develop a conceptual framework of staff's views of a supported employment program for persons with severe mental illness. J Consult Clin Psychol 62 (1994) 766-777
36. Walter S.D., Eliasziw M., and Donner A. Sample size and optimal designs for reliability studies. Statistics Med 17 (1998) 101-110
37. Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN. Psychiatric history and psychological adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain. (in press).
38. Winer B.J. Statistical Principles in Experimental Design. 3rd ed. (1991), McGraw-Hill, New York